long-acting HIV treatment – Discover Pharma

Welcome to Discover Pharma! Today is : November 2, 2026

long-acting HIV treatment

Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study
ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

October 6, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
ViiV’s Cabenuva shows superior HIV control to daily oral therapy in adolescents
ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

July 30, 2026
Clinical & Regulatory
European HIV survey finds gap in long-acting treatment conversations
A European survey of more than 1,900 people living with [...]

July 29, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK